Cargando…
Current Adenosinergic Therapies: What Do Cancer Cells Stand to Gain and Lose?
A key objective in immuno-oncology is to reactivate the dormant immune system and increase tumour immunogenicity. Adenosine is an omnipresent purine that is formed in response to stress stimuli in order to restore physiological balance, mainly via anti-inflammatory, tissue-protective, and anti-nocic...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617980/ https://www.ncbi.nlm.nih.gov/pubmed/34830449 http://dx.doi.org/10.3390/ijms222212569 |